"No other provider in Central Indiana is home to more cardiovascular innovation, coordinated care and talent than Community Heart and Vascular Hospital. Our heart physicians and specialists are dedicated to providing groundbreaking, comprehensive heart and vascular care. No other facility is as advanced in diagnostic and interventional cardiology, cardiovascular surgery, electrophysiology and atrial fibrillation treatment, cardiac rehabilitation and more. As one of the nation's first all-digital hospitals, with Indiana's first Cardiovascular Genetic Center of Excellence, we are the best choice when it comes to matters of the heart. If it has anything to do with your heart, it has everything to do with us."

During the past decade, Community Heart and Vascular Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Community Heart and Vascular Hospital" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "United Therapeutics" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Biotronik, Inc." with 1 trials sponsored and "Cook Research Incorporated" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Community Heart and Vascular Hospital" #1 collaborator was "University of Zurich" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Community Heart and Vascular Hospital" are "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials), "Aortic Aneurysm, Abdominal" (1 trials), "Cardiac Arrhythmia" (1 trials) and "Combined Pulmonary Fibrosis and Emphysema" (1 trials). Many other conditions were trialed in "Community Heart and Vascular Hospital" in a lesser frequency.

Most popular intervention types in "Community Heart and Vascular Hospital" are "Device" (6 trials) and "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "3 months of dual antiplatelet therapy (DAPT)" (1 trials), "Aspirin" (1 trials), "Implantable Cardioverter Defibrillator with Cardiac Resynchronization Therapy (BIOTRONIK Lumax HF-T CRT-D)" (1 trials), "Inhaled Treprostinil" (1 trials) and "Investigational LUX-Dx ICM Implant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Community Heart and Vascular Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Community Heart and Vascular Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Community Heart and Vascular Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Community Heart and Vascular Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".